查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1886576

人工智慧诊断市场－全球产业规模、份额、趋势、机会和预测，按组件、诊断类型、地区和竞争格局划分，2020-2030年预测

Artificial Intelligence Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Component, By Diagnosis Type, By Region and Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

2024年全球人工智慧诊断市场规模为21亿美元，预计2030年将以7.02%的复合年增长率成长至31.6亿美元。全球人工智慧诊断市场涵盖人工智慧演算法和机器学习技术在分析各种医疗资料（包括影像、基因组序列和患者记录）方面的应用，旨在提高疾病的检测、诊断和预后能力。市场扩张的主要驱动因素包括全球慢性病盛行率的不断上升、对早期准确疾病识别的迫切需求以及医疗保健系统对提高诊断效率的必要性。

市场概览
预测期 2026-2030
市场规模：2024年 21亿美元
市场规模：2030年 31.6亿美元
复合年增长率：2025-2030年 7.02%
成长最快的细分市场 肿瘤学
最大的市场 北美洲

主要市场驱动因素

人工智慧技术的进步是全球人工智慧诊断市场成长的主要驱动力。机器学习演算法、深度学习模型和运算处理能力的持续创新，显着提升了人工智慧系统解读复杂医疗资料的能力，使其更加精准。

主要市场挑战

复杂且不断演变的监管框架对全球人工智慧诊断市场的成长构成重大阻碍。这种环境要求严格的验证和广泛的审批流程，这直接延长了产品开发週期，并大幅提高了新技术进入市场的成本。

主要市场趋势

人工智慧与穿戴式装置和持续监测技术的融合，显着拓展了诊断能力，使其超越了传统的临床环境。这些人工智慧驱动的穿戴式装置能够持续采集生命征象和生理资料，从而实现即时评估和早期异常检测，进而进行主动健康管理。

目录

第一章：产品概述

第二章：研究方法

第三章：执行概要

第四章：顾客之声

第五章：全球人工智慧诊断市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 按组件（软体、硬体、服务）
    • 依诊断类型（心臟科、肿瘤学、病理学、放射学、神经病学、其他）
    • 按地区
    • 按公司（2024 年）
  • 市场地图

第六章：北美人工智慧诊断市场展望

  • 市场规模及预测
  • 市占率及预测
  • 北美洲：国家分析
    • 美国
    • 加拿大
    • 墨西哥

第七章：欧洲人工智慧诊断市场展望

  • 市场规模及预测
  • 市占率及预测
  • 欧洲：国家分析
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙

第八章：亚太地区人工智慧诊断市场展望

  • 市场规模及预测
  • 市占率及预测
  • 亚太地区：国家分析
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲

第九章：中东和非洲人工智慧诊断市场展望

  • 市场规模及预测
  • 市占率及预测
  • 中东和非洲：国家分析
    • 沙乌地阿拉伯
    • 阿联酋
    • 南非

第十章：南美洲人工智慧诊断市场展望

  • 市场规模及预测
  • 市占率及预测
  • 南美洲：国家分析
    • 巴西
    • 哥伦比亚
    • 阿根廷

第十一章：市场动态

  • 司机
  • 挑战

第十二章：市场趋势与发展

  • 併购
  • 产品发布
  • 最新进展

第十三章：全球人工智慧诊断市场：SWOT分析

第十四章：波特五力分析

  • 产业竞争
  • 新进入者的潜力
  • 供应商议价能力
  • 顾客的力量
  • 替代产品的威胁

第十五章：竞争格局

  • Vuno Inc.
  • CHC Healthcare Group
  • AIDoc Medical Ltd.
  • Imbio
  • AliveCor, Inc.
  • Digital Diagnostics Inc.
  • Retina AI, Inc.
  • Canon Medical Systems Corp.
  • Healthy.io Ltd
  • Milliman, Inc.

第十六章：策略建议

第17章调查会社について・免责事项

简介目录
Product Code: 22230

The Global Artificial Intelligence Diagnostics Market, valued at USD 2.10 Billion in 2024, is projected to experience a CAGR of 7.02% to reach USD 3.16 Billion by 2030. The Global Artificial Intelligence Diagnostics Market encompasses the application of AI algorithms and machine learning techniques to analyze diverse medical data, including imaging, genomic sequences, and patient records, for enhanced disease detection, diagnosis, and prognosis. Market expansion is primarily supported by the increasing global prevalence of chronic diseases, the critical demand for early and accurate disease identification, and the necessity for improved diagnostic efficiency within healthcare systems.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 2.10 Billion
Market Size 2030USD 3.16 Billion
CAGR 2025-20307.02%
Fastest Growing SegmentOncology
Largest MarketNorth America

Key Market Drivers

Advancements in artificial intelligence technologies represent a primary catalyst for growth within the global artificial intelligence diagnostics market. Continuous innovation in machine learning algorithms, deep learning models, and computational processing power has significantly enhanced the capability of AI systems to interpret complex medical data with greater precision. For example, according to "Advancements in Artificial Intelligence for Medical Computer-Aided Diagnosis," June 2024, an optimized XGBoost model achieved 98.50% accuracy in enhancing diagnostic accuracy for heart disease, demonstrating the tangible improvements these technologies bring to diagnostic precision.

Key Market Challenges

The complex and continuously evolving regulatory frameworks governing AI-powered diagnostic solutions present a significant impediment to the growth of the Global Artificial Intelligence Diagnostics Market. This environment mandates rigorous validation and extensive approval processes, which directly prolong product development timelines and substantially elevate the costs associated with market entry for new technologies. Such demands necessitate considerable investment in regulatory compliance and specialized expertise, forming a critical barrier for manufacturers.

Key Market Trends

The integration of AI with wearable devices and continuous monitoring is significantly expanding diagnostic capabilities beyond traditional clinical environments. These AI-powered wearables continuously collect vital signs and physiological data, enabling real-time assessment and early anomaly detection for proactive health management. The growing acceptance of AI in clinical practice is evident as the American Medical Association reported physician usage of AI surged from 38% in 2023 to 66% in 2024, indicating increasing trust in these tools.

Key Market Players

  • Vuno Inc.
  • CHC Healthcare Group
  • AIDoc Medical Ltd.
  • Imbio
  • AliveCor, Inc.
  • Digital Diagnostics Inc.
  • Retina AI, Inc.
  • Canon Medical Systems Corp.
  • Healthy.io Ltd
  • Milliman, Inc.

Report Scope:

In this report, the Global Artificial Intelligence Diagnostics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Artificial Intelligence Diagnostics Market, By Component:

  • Software
  • Hardware
  • Services

Artificial Intelligence Diagnostics Market, By Diagnosis Type:

  • Cardiology
  • Oncology
  • Pathology
  • Radiology
  • Neurology
  • Others

Artificial Intelligence Diagnostics Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Artificial Intelligence Diagnostics Market.

Available Customizations:

Global Artificial Intelligence Diagnostics Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Artificial Intelligence Diagnostics Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Component (Software, Hardware, Services)
    • 5.2.2. By Diagnosis Type (Cardiology, Oncology, Pathology, Radiology, Neurology, Others)
    • 5.2.3. By Region
    • 5.2.4. By Company (2024)
  • 5.3. Market Map

6. North America Artificial Intelligence Diagnostics Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Component
    • 6.2.2. By Diagnosis Type
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Artificial Intelligence Diagnostics Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Component
        • 6.3.1.2.2. By Diagnosis Type
    • 6.3.2. Canada Artificial Intelligence Diagnostics Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Component
        • 6.3.2.2.2. By Diagnosis Type
    • 6.3.3. Mexico Artificial Intelligence Diagnostics Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Component
        • 6.3.3.2.2. By Diagnosis Type

7. Europe Artificial Intelligence Diagnostics Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Component
    • 7.2.2. By Diagnosis Type
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Artificial Intelligence Diagnostics Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Component
        • 7.3.1.2.2. By Diagnosis Type
    • 7.3.2. France Artificial Intelligence Diagnostics Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Component
        • 7.3.2.2.2. By Diagnosis Type
    • 7.3.3. United Kingdom Artificial Intelligence Diagnostics Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Component
        • 7.3.3.2.2. By Diagnosis Type
    • 7.3.4. Italy Artificial Intelligence Diagnostics Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Component
        • 7.3.4.2.2. By Diagnosis Type
    • 7.3.5. Spain Artificial Intelligence Diagnostics Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Component
        • 7.3.5.2.2. By Diagnosis Type

8. Asia Pacific Artificial Intelligence Diagnostics Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Component
    • 8.2.2. By Diagnosis Type
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Artificial Intelligence Diagnostics Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Component
        • 8.3.1.2.2. By Diagnosis Type
    • 8.3.2. India Artificial Intelligence Diagnostics Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Component
        • 8.3.2.2.2. By Diagnosis Type
    • 8.3.3. Japan Artificial Intelligence Diagnostics Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Component
        • 8.3.3.2.2. By Diagnosis Type
    • 8.3.4. South Korea Artificial Intelligence Diagnostics Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Component
        • 8.3.4.2.2. By Diagnosis Type
    • 8.3.5. Australia Artificial Intelligence Diagnostics Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Component
        • 8.3.5.2.2. By Diagnosis Type

9. Middle East & Africa Artificial Intelligence Diagnostics Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Component
    • 9.2.2. By Diagnosis Type
    • 9.2.3. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Artificial Intelligence Diagnostics Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Component
        • 9.3.1.2.2. By Diagnosis Type
    • 9.3.2. UAE Artificial Intelligence Diagnostics Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Component
        • 9.3.2.2.2. By Diagnosis Type
    • 9.3.3. South Africa Artificial Intelligence Diagnostics Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Component
        • 9.3.3.2.2. By Diagnosis Type

10. South America Artificial Intelligence Diagnostics Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Component
    • 10.2.2. By Diagnosis Type
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Artificial Intelligence Diagnostics Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Component
        • 10.3.1.2.2. By Diagnosis Type
    • 10.3.2. Colombia Artificial Intelligence Diagnostics Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Component
        • 10.3.2.2.2. By Diagnosis Type
    • 10.3.3. Argentina Artificial Intelligence Diagnostics Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Component
        • 10.3.3.2.2. By Diagnosis Type

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Artificial Intelligence Diagnostics Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Vuno Inc.
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. CHC Healthcare Group
  • 15.3. AIDoc Medical Ltd.
  • 15.4. Imbio
  • 15.5. AliveCor, Inc.
  • 15.6. Digital Diagnostics Inc.
  • 15.7. Retina AI, Inc.
  • 15.8. Canon Medical Systems Corp.
  • 15.9. Healthy.io Ltd
  • 15.10. Milliman, Inc.

16. Strategic Recommendations

17. About Us & Disclaimer